CLICK HERE to browse additional heart failure case reviews.
Want to submit your original clinical case study to a SCAI.org Clinical Interest Section?
CLICK HERE to learn more about how to submit your Image Review presentation.
Advertisment
SCAI HEART FAILURE CENTER features a variety of resources aimed at helping interventional cardiologists and other members of the cardiovascular care team become proficient in the latest protected PCI and cardiogenic shock techniques — whether you are at a beginner or advanced training level.
Dr. Yoram Amsalem of Montefiore-Einstein Center for Heart and Vascular Care shares a case of a frail 69 year-old female with NSTEMI, multi-vessel CAD, severe MR and reduced LVEF. REVIEW CASE
Dr. William O’Neill of Detroit’s Henry Ford Hospital explains why Impella will be a major advancement for the treatment of cardiogenic shock. His prognosis is based in part on his performed registry which found the survival of over 60% in patients that were treated very early. Dr. O’Neill’s finding were used for FDA approval of the Impella device for cardiogenic shock. WATCH VIDEO
Dr. Patrick Hall from University Hospital in Augusta Georgia speaks about a 46 year old patient with cardiogenic shock and acute left main occlusion. Listen to this very instructive, successful case of complete revascularization with the help of Impella® for hemodynamic support. REVIEW CASE
Ochsner Medical Center’s Dr. Rajan Patel presents practical Impella use and management strategies, and also tips and tricks at the Impella Certified Experts (ICE) program in New Orleans. He discusses Impella device options, patient management topics (Impella in Dextrocardia) and several case reviews. This presentation is an excellent introduction for doctors, nurses and techs who are new to the Impella platform of products and a great review for current users. REVIEW CASE
Northwell Health’s Dr. Michael Happes shares a case of a dramatic save of a postcardiotomy cardiogenic shock patient. In this case the Impella RP provided critical right side support. REVIEW CASE
Mechanical circulatory support with impella to facilitate percutaneous coronary intervention for post-TAVI bilateral coronary obstruction1 July 2016
Emergent use of Impella CP™ during transcatheter aortic valve replacement: Transaortic access1 July 2015
Feasibility and efficacy of the 2.5 L and 3.8 L impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis1 May 2015
Removal of Impella® 2.5 while maintaining vascular access: A solution to a vascular quandary1 February 2014
Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: The USpella Registry1 November 2012
Cardiogenic shock secondary to severe acute ischemic mitral regurgitation managed with an impella 2.5 percutaneous left ventricular assist device1 June 2012
Left ventricular assistant device impella 2.5 usage for patients undergoing high-risk PCI1 June 2012
The SCAI Heart Failure Center is developed and maintained with the generous support of Abiomed. SCAI gratefully acknowledges this support, while taking sole responsibility for all content developed and disseminated through this effort.
Navin K. Kapur, MD, FSCAIView Bio
Srihari S. Naidu, MD, FSCAIView Bio
SCAI® is a registered trademark of The Society for Cardiovascular Angiography and Interventions.
The Society for Cardiovascular Angiography and Interventions, 1100 17th Street NW, Suite 400, Washington, DC 20036
Phone: 202-741-9854 | Toll Free: 800-992-7224 | Fax: 202-689-7224 | Email: info@scai.org
Terms & Conditions
